Harmony Biosciences

We are excited to share that Harmony Biosciences has been ranked among the top 25 fastest growing companies in North America by Deloitte Technology’s Fast 500?. At Harmony Biosciences, our growth story is a testament to the strength of our business. We are unwavering in our pursuit of bringing potential, next-generation, innovative treatments to people living with rare neurological disease who have unmet medical needs, and we thank all our team members across the organization for their hard work, passion and commitment to the patients, customers, and communities we serve. Read more: https://lnkd.in/ev8PTq8 #Fast500

In December,?Harmony Biosciences’ Management Team will be participating in two conferences: - Citi’s 2024 Global Healthcare Conference (Dec. 3) - Piper Sandler 36th Annual Healthcare Conference (Dec. 4) We invite you to join us and learn about our evolving pipeline and commitment to developing new treatment options for people living with rare neurological diseases who have unmet medical needs. More information: https://lnkd.in/ee_qhXZj

As Harmony Biosciences has expanded its commitment to the rare disease community in recent years, our mission remains the same: deliver innovative and novel treatments while guided by our core principles of empathy and innovation. Learn more: https://bit.ly/47ZmBEE #pharma #biosciences #lifesciences

We are so excited and proud of our President and CEO, Jeffrey Dayno, MD, for receiving this honor from Life Science Cares Philadelphia! Congratulations, Jeff, on this much-deserved recognition.

With a growing pipeline of innovative solutions, Harmony Biosciences’ patient-focused drug development model allows us to build a pipeline focused on potential, next-generation, innovative treatments to help people living with rare neurological disease and unmet medical needs. Discover more about who we are and our new era of #Newrology: https://bit.ly/47ZmBEE #Biosciences #Innovation

It is estimated that #NursePractitioners (NPs) conduct over 1 billion patient visits per year evaluating patients, ordering and interpreting tests, making diagnoses, and writing prescriptions. They approach healthcare challenges with empathy and clinical expertise, often serving as a central part of a patient's experience. This #NPWeek, we proudly join American Association of Nurse Practitioners and others nationwide to celebrate the invaluable contributions of NPs. #raredisease #careteam

As we recognize #VeteransDay and honor those who have served in the United States Armed Forces, we are proud to feature our team member Christina Colley, a Captain in the United States Army Reserve, who also works full-time on our Technical Operations team. Click through to see what drives Christina’s passion for the work she does at Harmony Biosciences and how her military background translates to her daily work. #InHarmony #GPTWcertified?

In our work with rare neurological diseases, we are humbled and continually inspired by the caregivers we meet. We recognize that #CaregivingAroundTheClock is a daily reality for many caregivers and your dedication is crucial to the wellbeing of those you care for. Thank you for all that you do! #NationalFamilyCaregiversMonth ? #caregivers

Today is International #LennoxGastautAwarenessDay and the start of #EpilepsyAwarenessMonth. Lennox-Gastaut syndrome (LGS) is a severe form of #epilepsy, with seizures that can begin in early childhood. The majority of people living with LGS may experience developmental delays, behavioral disturbances, and impaired intellectual functioning or information processing. Join us in helping to raise awareness of #LennoxGastautSyndrome (#LGS). Learn more about LGS here: https://bit.ly/4dCLGWR #raredisease #rarediseases #LennoxGastaut #LennoxGastautSyndrome

Earlier today, Harmony Biosciences announced the Company’s Q3 2024 financial results. Read our news release for more information: https://lnkd.in/e87zyT7P